Loading...
Cost-Effectiveness of Chemoprevention with Proton Pump Inhibitors in Barrett’s Esophagus
BACKGROUND: Proton pump inhibitors (PPIs) may reduce the risk of esophageal adenocarcinoma (EAC) in patients with Barrett’s esophagus. PPIs are prescribed for virtually all patients with Barrett’s esophagus, irrespective of the presence of reflux symptoms, and represent a de facto chemopreventive ag...
Na minha lista:
| Udgivet i: | Dig Dis Sci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4315516/ https://ncbi.nlm.nih.gov/pubmed/24795040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-014-3186-3 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|